Neuroimaging alterations associated with medication use in early-onset bipolar disorder: An updated review
Journal of Affective Disorders · 2023
DOI: 10.1016/j.jad.2023.07.098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von Parya Valizadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tehran University of Medical Science, Tehran, Iran; Neuroscience Research Group (NRG), Universal Scientific Education and Researc…. Hauptthemen laut MEDLINE: Bipolar Disorder, Antipsychotic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pediatric bipolar disorder (PBD) is a severe disorder characterized by mood fluctuations starting at a young age. Several neuroimaging studies revealed a specific biological signature of PBD involving alterations in the amygdala and prefrontal regions. Considering the growing concerns regarding the effects of PBD treatments on developing brains, this review aims to provide an overview of the studies investigating the effect of mood stabilizers, antipsychotics, and anticonvulsants on neuroimaging findings in PBD. METHODS: We searched PubMed, Scopus, and Web of Science to identify all structural magnetic resonance imaging (sMRI), functional magnetic resonance imaging (fMRI), and diffusion tensor imaging (DTI) studies exploring the effects of medications on neuroimaging findings in PBD. A total of 18 studies met our inclusion criteria (fMRI n = 11, sMRI n = 6, DTI n = 1). RESULTS: Although the findings varied highly across the studies, some investigations consistently indicated that medications primarily affect the prefrontal cortex and the amygdala. Moreover, despite some exceptions, the reported medication effects predominantly lean towards structural and functional normalization. LIMITATIONS: The reviewed studies differ in methods, medications, and fMRI paradigms. Furthermore, most studies used observational approaches with small sample sizes, minimizing the statistical power. CONCLUSIONS: Evidence suggests the potential of antipsychotics and mood stabilizers to modulate the neuroimaging findings in PBD patients, mostly normalizing brain structure and function in key mood-regulating regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Tehran University of Medical Science, Tehran, Iran; Neuroscience Research Group (NRG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- Department of Neuroscience (DNS), Padua Neuroscience Center, University of Padova, Padua, Italy; Padua Neuroscience Center, University of Padova, Padua, Italy.
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: giuseppe.delvecchio@policlinico.mi.it.
Zitieren
APA
Valizadeh, P., Cattarinussi, G., Sambataro, F., Brambilla, P., & Delvecchio, G. (2023). Neuroimaging alterations associated with medication use in early-onset bipolar disorder: An updated review. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.07.098
Vancouver
Valizadeh P, Cattarinussi G, Sambataro F, Brambilla P, Delvecchio G. Neuroimaging alterations associated with medication use in early-onset bipolar disorder: An updated review. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.07.098
BibTeX
@article{Valizadeh2023,
author = {Valizadeh, Parya and Cattarinussi, Giulia and Sambataro, Fabio and Brambilla, Paolo and Delvecchio, Giuseppe},
title = {Neuroimaging alterations associated with medication use in early-onset bipolar disorder: An updated review},
journal = {Journal of Affective Disorders},
year = {2023},
doi = {10.1016/j.jad.2023.07.098}
}
EUVIMED